New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies

Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed...

Related Keywords

Switzerland , United States , Japan , American , America , Birgit Masjost , Robert Wood , Rebekka Schnell , Nathalie Altermatt , Bruno Eschli , Levi Garraway , Sabine Borngr , Kirti Pandey , Simon Goldsborough , R Sharon Chinthrajah , Karsten Kleine , Loren Kalm , Sileia Urech , Head Of Global Product Development , Johns Hopkins Children Center , Genentech Inc , Drug Administration , Novartis Pharmaceuticals Corporation , Consortium For Food Allergy Research Co , National Institute Of Allergy , Public Health Impact Of Parent , Asthma Research , Roche Group , Inspection Service , Eudowood Division Of Allergy , American Academy Of Allergy , Genentech , National Institutes Of Health , Stanford School Of Medicine , Seann Parker Center , National Institutes , New England Journal , Eudowood Division , Johns Hopkins Children , Stanford School , Secondary Endpoints Results , Paediatric Population , Key Secondary , Additional Secondary , Chief Medical Officer , Global Product , Adjunct Therapy , Food Allergic Children , National Institute , Infectious Diseases , Food Allergy Research , Novartis Pharmaceuticals , Dow Jones Sustainability Indices , Chugai Pharmaceutical , Food Allergies Among , Public Health Impact , Parent Reported Childhood Food Allergies , Accessed November , Food Equivalents , Food Allergy , Environmental Factors , Accessed February ,